LD50 LC50 Mixture:ORAL LD50 (RAT): 8.7 MG/KG (SEE SUPP)
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION/INGESTION/SKIN/EYES:
LONG-TERM OVEREXPOSURE MAY CAUSE SUSCEPTIBILITY TO BRUISING/LONGER
BLOOD-CLOTTING TIMES/APPEARANCE OF BLOOD IN STOOL/URINE/EXCESSIVE
MENSTRUAL BLEEDING/RED/PURPLE SPOTS /BLOTCHES ON SKIN/PERSISTENT
OOZING OF SUPERFICIAL INJURIES.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:INHALATION/INGESTION/SKIN/EYES: LONG TERM
OVEREXPOSURE MAY CAUSE SUSCEPTIBILITY TO BRUISING/LONGER
BLOOD-CLOTTING TIMES/BLOOD IN STOOL/URINE/EXCESSIVE MENSTRUAL
BLEEDING/RED/PURPLE SPOTS/BLOTCHES ON S KIN/PERSISTENT OOZING FROM
SUPERFICIAL INJURIES.
Medical Cond Aggravated by Exposure:PRE-EXISTING DISEASES OF THE BONE
MARROW.
======================= First Aid Measures =======================
First Aid:INHALATION: REMOVE TO FRESH AIR. GIVE CPR/OXYGEN IF REQUIRED.
SKIN: WASH W/SOAP & WATER. EYES: FLUSH W/WATER FOR 15 MINS.
INGESTION: IMMEDIATELY GIVE 2 GLASSES OF WATER & INDUCE VOMITING.
NEVER GIVE A NYTHING TO AN UNCONSCIOUS PERSON. OBTAIN MEDICAL
ATTENTION IN ALL CASES. NOTE TO PHYSICIAN: PRODUCT IS INDICATED FOR
PHROPHYLAXIS/TREATMENT OF VENOUS THROMBOSIS & ITS EXTENSION, (SEE
SUPP)
===================== Fire Fighting Measures =====================
Extinguishing Media:WATER SPRAY, FOAM, DRY POWDER, DRY CHEMICAL, CO2.
Fire Fighting Procedures:EVACUATE PERSONNEL TO A SAFE AREA.
Spill Release Procedures:USE APPROPRIATE PERSONAL PROTECTIVE EQUIPMENT.
RECOVER UNDAMAGED/MINIMALLY CONTAMINATED MATERIAL FOR
REUSE/RECLAMATION. AVOID DUST GENERATION.
====================== Handling and Storage ======================
Handling and Storage Precautions:DON'T STORE/CONSUME FOOD/DRINK/TOBACCO
IN AREAS WHERE THEY MAY BECOME CONTAMINATED W/THIS MATERIAL. STORE
59-86F. PROTECT FROM LIGHT.
Other Precautions:AVOID DUST GENERATION. CLOSE CONTAINER AFTER EACH
USE. KEEP CONTAINER TIGHTLY CLOSED. AVOID BREATHING DUST, CONTACT
W/EYES/SKIN/CLOTHING.
Respiratory Protection:WEAR NIOSH/MSHA APPROVED AIR PURIFYING
RESPIRATOR/POSITIVE PRESSURE AIR-SUPPLIED RESPIRATOR WHEN JUDGED
APPROPRIATE TO PREVENT INHALATION OF DUST.
Protective Gloves:NEOPRENE, TYVEK
Eye Protection:SAFETY GLASSES & FULL FACE SHIELD
Other Protective Equipment:NEOPRENE/TYVEK APRON, BOOTS, JUMPSUIT, WHOLE
BOBYSUIT.
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE. WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health
LD50 DATA IS FOR WARFARIN SODIUM. NOTE TO PHYSICIAN CONT'D: PULMONARY
EMBOLISM/THROMBOEMBOLISM ASSOCIATED W/ATRIAL FIBRILLATION & AS AN
ADJUNCT IN PROPHYLAXIS OF SYSTEMIC EMBOLISM AFTER MYOCARDIAL INF
ARCTION. ANTICOAGULANT EFFECT GENERALLYOCCURS W/IN 24 HRS, MAY BE
DELAYED 72-96 HRS, & MAY PERSIST FOR 4-5 DAYS.
Waste Disposal Methods:DISPOSE OF IAW/FEDERAL, STATE & LOCAL
REGULATIONS. INNER PACKAGINGS SHOULD CONTAIN NO MORE THAN 5 KG OF
THIS PRODUCT.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.